W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

Transparency Council

Home » dFlip Book » Tag: Transparency Council(Strona 4)
22 February, 2023

Position of the Transparency Council – Reducto spezial (potassium dihydrogen phosphate, sodium monohydrogen phosphate)

more...
22 February, 2023

Position of the Transparency Council – Fostex Nexthaler (beclometasone dipropionate) anhydrous + formoterol fumarate dihydrate

more...
21 February, 2023

The Transparency Council meeting 9/2023 on 27 February 2023

more...
16 February, 2023

Meeting of the Transparency Council 8/2023 on 20 February 2023 – UPDATE

more...
14 February, 2023

The Meeting of the Transparency Council No. 8/2023 of 20.02.2023

more...
10 February, 2023

The Meeting of the Transparency Council No. 7/2023 of 13.02.2023

more...
17 January, 2023

The Meeting of the Transparency Council No. 4/2023 of 23.01.2023

more...
11 January, 2023

Meeting of the Transparency Council No. 3/2023 of 16.01.2023

more...
02 January, 2023

The Meeting of the Transparency Council No. 2/2023 of 09.01.2023

more...
30 December, 2022

Meeting of the Transparency Council No. 1/2023 of 02.01.2023 – UPTADE

more...
22 December, 2022

Meeting of the Transparency Council No. 1/2023 of 02.01.2023

more...
21 December, 2022

Meeting of the Transparency Council No. 51/2022 of 27.12.2022

more...
14 December, 2022

Meeting of the Transparency Council No. 50/2022 of 19.12.2022 – UPTADE

more...
13 December, 2022

Meeting of the Transparency Council No. 50/2022 of 19.12.2022

more...
08 December, 2022

Meeting of the Transparency Council No. 49/2022 of 12.12.2022

more...
02 December, 2022

Meeting of the Transparency Council No. 48/2022 of 05.12.2022 r. – UPDATED

more...
20 September, 2022

Opinion of the Transparency Council – tacrolimus

more...
20 September, 2022

. Opinion of the Transparency Council – chlorambucil

more...
20 September, 2022

Opinion of the Transparency Council – sulfamethoxazole + trimethoprim

more...
20 September, 2022

Opinion of the Transparency Council – amoxicillin + clavulanic acid

more...
20 September, 2022

Opinion of the Transparency Council – amoxicillin

more...
20 September, 2022

Opinion of the Transparency Council – bisoprolol

more...
20 September, 2022

Opinion of the Transparency Council – spironolactone

more...
20 September, 2022

Resolution of the Transparency Council on the effective cost of treatment

more...
Home page
News Publications Publikacje BIP
#webinaragendaAktualnościannouncement of the PresidentazathioprinumBimzelxCollegium AOTMiTcolorectal cancercommunicationCommunication from the Transparency CouncilCommunication on the Tariff CouncilCost Accounting StandardCouncil for Tariffs Affairscovering neonatal carecyclophosphamidumData acquisitiondental treatment servicesdiseases of the organ of visiondrug programmeEmplicitientecavirumetanerceptFycompagastroscopyglaucomahealth policy programhealth policy programmehealth policy programme on breast cancerhealth policy programme on infertility treatmentHealth Policy ProgrammesImpavidoin vitroInovelonJardianceMeeting of the Transparency CouncilmethotrexatumMilupa Basic-Pminimum wage increasesmycophenolate mofetilnewnew tariffsnewsNoticeNotice of the PresidentOntozryOnuregOpdivoOpdivo (nivolumab)opinionOpinion of the PresidentOpinion of the Transparency CouncilOspolotOzurdexperinatal carePonvoryPosition of the Transparency CouncilPress conferenceRecommendationRecommendation of the PresidentRenastepreportRezurocksirolimusSuliquaTariff CouncilTariffs CouncilTarification Plan 2025tenofovirum disoproxilumthe drug programme B.44the drug programme B.82The Meeting of the Tariffs CounciltrainingsTransparency CouncilTremfyaupdateVivitrolYervoy
Pokaż więcej ↓
Pokaż mniej ↑
Telefon
Email